Showing results (21-30 of 298) with videos related to

Sort By:
Pageof 30
Cancer Science|November 24, 2015
Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunctionTakashi Shibata, Tomoki Ebata, Ken-ichi Fujita, et al.
Cancer Medicine|February 13, 2024
Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancerOsamu Maeda, Satoshi Furune, Mitsuro Kanda, et al.
Asia-Pacific Journal of Clinical Oncology|July 5, 2023
A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomyYao Liang, Osamu Maeda, Kazushi Miyata, et al.
Molecular and Clinical Oncology|October 4, 2014
Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancerOsamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, et al.
International Journal of Colorectal Disease|July 18, 2020
What is the impact of systemic chemotherapy for lateral lymph nodes in patients with locally advanced low rectal cancer?Atsushi Ogura, Kay Uehara, Toshisada Aiba, et al.
International Cancer Conference Journal|February 4, 2022
Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancerYuko Takano, Satoshi Furune, Yuki Miyai, et al.
World Journal of Gastroenterology|March 2, 2017
Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility studyOsamu Maeda, Ayumu Matsuoka, Ryoji Miyahara, et al.
Oncology Letters|December 2, 2015
FOLFIRINOX-induced reversible dysarthria: A case report and review of previous casesAyumu Matsuoka, Osamu Maeda, Megumi Inada-Inoue, et al.
Clinical Journal of Gastroenterology|July 18, 2015
A patient with esophageal cancer with bone metastasis who achieved pain relief with repetitive administration of strontium-89 chlorideOsamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, et al.
International Cancer Conference Journal|January 8, 2024
Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcomaYao Liang, Osamu Maeda, Tomoya Shimokata, et al.
Pageof 30